Calvin Sternick
Stock Analyst at JP Morgan
(2.47)
# 2,245
Out of 4,786 analysts
19
Total ratings
38.46%
Success rate
6.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Calvin Sternick
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
USPH U.S. Physical Therapy | Maintains: Overweight | $120 → $110 | $72.36 | +52.02% | 5 | Mar 19, 2025 | |
CNC Centene | Maintains: Neutral | $85 → $80 | $60.71 | +31.77% | 4 | Jul 10, 2024 | |
PACS PACS Group | Initiates: Overweight | $27 | $11.24 | +140.21% | 1 | May 6, 2024 | |
UHS Universal Health Services | Maintains: Neutral | $144 → $182 | $187.90 | -3.14% | 3 | Mar 13, 2024 | |
THC Tenet Healthcare | Maintains: Overweight | $91 → $81 | $134.50 | -39.78% | 2 | Nov 17, 2023 | |
MOH Molina Healthcare | Maintains: Overweight | $367 → $392 | $329.39 | +19.01% | 4 | Nov 17, 2023 |
U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120 → $110
Current: $72.36
Upside: +52.02%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85 → $80
Current: $60.71
Upside: +31.77%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $11.24
Upside: +140.21%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144 → $182
Current: $187.90
Upside: -3.14%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91 → $81
Current: $134.50
Upside: -39.78%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367 → $392
Current: $329.39
Upside: +19.01%